Repurposing the orphan drug nitisinone synergizes with sorafenib to sensitize immunotherapy-refractory MSS-CRC via metabolic stress-driven STING activation
Minshan Wu, Guannan Tang, Minghui Liu, Xiaoshu Wang, Yumo Xie, Yuanhui Wu et al. Repurposing the orphan drug nitisinone synergizes with sorafenib to sensitize immunotherapy-refractory MSS-CRC via metabolic stress-driven STING activation. // Pharmacological Research. – 2026. – DOI: 10.1016/j.phrs.2026.109724. – URL: https://doi.org/10.1016/j.phrs.2026.109724
Minshan Wu, Guannan Tang, Minghui Liu, Xiaoshu Wang, Yumo Xie, Yuanhui Wu, Jinxin Lin, Jingrong Weng, Xiaolin Wang, Huichuan Yu, Meijin Huang, Shaochun Yuan, Yanxin Luo, & Xiaoxia Liu (2026). Repurposing the orphan drug nitisinone synergizes with sorafenib to sensitize immunotherapy-refractory MSS-CRC via metabolic stress-driven STING activation. Pharmacological Research. https://doi.org/10.1016/j.phrs.2026.109724
Minshan Wu, et al. “Repurposing the orphan drug nitisinone synergizes with sorafenib to sensitize immunotherapy-refractory MSS-CRC via metabolic stress-driven STING activation.” Pharmacological Research, 2026. doi:10.1016/j.phrs.2026.109724.
@article{Wu2026,
title = {Repurposing the orphan drug nitisinone synergizes with sorafenib to sensitize immunotherapy-refractory MSS-CRC via metabolic stress-driven STING activation},
author = {Wu, Minshan and Tang, Guannan and Liu, Minghui and Wang, Xiaoshu and Xie, Yumo and Wu, Yuanhui and Lin, Jinxin and Weng, Jingrong and Wang, Xiaolin and Yu, Huichuan and Huang, Meijin and Yuan, Shaochun and Luo, Yanxin and Liu, Xiaoxia},
journal = {Pharmacological Research},
year = {2026},
doi = {10.1016/j.phrs.2026.109724},
url = {https://doi.org/10.1016/j.phrs.2026.109724}
}